| 摘要 |
<p>The present invention is a method for inhibiting or reducing disease progression in subjects suffering from conditions or diseases related to the Aß peptide, including Alzheimer's disease, Down's syndrome, cerebral amyloid angiopathy, mild cognitive impairment, and the like. The method comprises administering an apoE2 lentiviral vector to the subject.</p> |
| 申请人 |
ELI LILLY AND COMPANY;THE SALK INSTITUTE FOR BIOLOGICAL STUDIES;BALES, KELLY, RENEE;DODART, JEAN-COSME, FRANCOIS;PAUL, STEVEN, MARC;MARR, ROBERT, A.;VERMA, INDER, MOHAN |
发明人 |
BALES, KELLY, RENEE;DODART, JEAN-COSME, FRANCOIS;PAUL, STEVEN, MARC;MARR, ROBERT, A.;VERMA, INDER, MOHAN |
